Where I see patients (1)
My reviews
Selected research
-
Long-term outcomes of patients with mucopolysaccharidosis VI treated with galsulfase enzyme replacement therapy since infancy.
Molecular genetics and metabolism
-
Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy.
Journal of inherited metabolic disease
-
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.
Journal of inherited metabolic disease
4.6